文献速递主动脉疾病

医生手术量与钝性胸主动脉损伤胸主动脉腔内修复术后结局的关系

Surgeon volume and outcomes following thoracic endovascular aortic repair for blunt thoracic aortic injury.
PubMed 文献 · J Vasc Surg · 2024-03-01

基于VQI 2013至2023年数据,分析1321例因钝性胸主动脉损伤行胸主动脉腔内修复术的患者,按医生年手术量五分位分组。校正中心和混杂因素后,中高容量医生组围术期死亡和缺血性/出血性卒中的比值比低于低容量医生组,且不依赖医院容量。

要点

  • 高医生手术量与TEVAR术后围术期死亡和卒中风险降低独立相关。
  • 年手术量≥2例的医生围术期死亡比值比较低容量医生降低约50%。
  • 高容量医生TEVAR更常延迟至4小时后或择期进行,肝素使用更多。

核心结论

  • 在因钝性胸主动脉损伤行TEVAR的患者中,较高的医生手术量与较低的围术期死亡率和术后卒中独立相关,且不受医院容量影响。

研究设计与样本

  • 回顾性分析血管质量倡议(VQI)数据库2013至2023年因钝性胸主动脉损伤行TEVAR的1321例患者。
  • 医生年手术量按每例手术前1年内实施的TEVAR总数计算并分为五分位,第一五分位为低容量(每年0-1例),最高五分位为高容量(每年≥9例),中间三个五分位为中容量(每年2-8例)。
  • 采用多水平logistic回归模型评估医生手术量与围术期结局的关联,校正年度中心容量及主动脉损伤分级、合并伤严重程度等混杂因素,并考虑患者和医生在同一中心内的嵌套聚类。
  • 排除在VQI中登记不足1年的医生所实施的TEVAR。
  • 进行排除IV级钝性胸主动脉损伤患者的敏感性分析。

主要发现

  • 低容量医生实施28%的TEVAR(每年0-1例),中容量医生实施52%(每年2-8例),高容量医生实施20%(每年≥9例)。
  • 随医生手术量增加,TEVAR更多延迟:4小时内完成低容量68%、中容量54%、高容量46%(P < .001);择期(>24小时)低容量5.1%、中容量8.9%、高容量14%。
  • 肝素使用率随医生手术量增加:低容量80%、中容量81%、高容量87%(P = .007)。
  • 围术期死亡率低容量11%、中容量7.3%、高容量6.5%(P = .095);缺血性/出血性卒中低容量6.5%、中容量3.6%、高容量1.5%(P = .006)。
  • 校正后与低容量医生相比,中容量医生围术期死亡比值比0.49(95%CI 0.25-0.97;P = .039),高容量医生0.45(95%CI 0.16-1.22;P = .12),中/高容量合并0.50(95%CI 0.26-0.96;P = .038)。

临床怎么用

  • 作者认为,未来研究可阐明非破裂性钝性胸主动脉损伤的TEVAR是否可延迟,以便稳定病情、肝素化并让更高TEVAR手术量的医生参与。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) for blunt thoracic aortic injury (BTAI) at high-volume hospitals has previously been associated with lower perioperative mortality, but the impact of annual surgeon volume on outcomes following TEVAR for BTAI remains unknown. METHODS: We analyzed Vascular Quality Initiative (VQI) data from patients with BTAI that underwent TEVAR between 2013 and 2023. Annual surgeon volumes were computed as the number of TEVARs (for any pathology) performed over a 1-year period preceding each procedure and were further categorized into quintiles. Surgeons in the first volume quintile were categorized as low volume (LV), the highest quintile as high volume (HV), and the middle three quintiles as medium volume (MV). TEVAR procedures performed by surgeons with less than 1-year enrollment in the VQI were excluded. Using multilevel logistic regression models, we evaluated associations between surgeon volume and perioperative outcomes, accounting for annual center volumes and adjusting for potential confounders, including aortic injury grade and severity of coexisting injuries. Multilevel models accounted for the nested clustering of patients and surgeons within the same center. Sensitivity analysis excluding patients with grade IV BTAI was performed. RESULTS: We studied 1321 patients who underwent TEVAR for BTAI (28% by LV surgeons [0-1 procedures per year], 52% by MV surgeons [2-8 procedures per year], 20% by HV surgeons [≥9 procedures per year]). With higher surgeon volume, TEVAR was delayed more (in <4 hours: LV: 68%, MV: 54%, HV: 46%; P < .001; elective (>24 hours): LV: 5.1%; MV: 8.9%: HV: 14%), heparin administered more (LV: 80%, MV: 81%, HV: 87%; P = .007), perioperative mortality appears lower (LV: 11%, MV: 7.3%, HV: 6.5%; P = .095), and ischemic/hemorrhagic stroke was lower (LV: 6.5%, MV: 3.6%, HV: 1.5%; P = .006). After adjustment, compared with LV surgeons, higher volume surgeons had lower odds of perioperative mortality (MV: 0.49; 95% confidence interval [CI], 0.25-0.97; P = .039; HV: 0.45; 95% CI, 0.16-1.22; P = .12; MV/HV: 0.50; 95% CI, 0.26-0.96; P = .038) and ischemic/hemorrhagic stroke (MV: 0.38; 95% CI, 0.18-0.81; P = .011; HV: 0.16; 95% CI, 0.04-0.61; P = .008). Sensitivity analysis found lower adjusted odds for perioperative mortality (although not significant) and ischemic/hemorrhagic stroke for higher volume surgeons. CONCLUSIONS: In patients undergoing TEVAR for BTAI, higher surgeon volume is independently associated with lower perioperative mortality and postoperative stroke, regardless of hospital volume. Future studies could elucidate if TEVAR for non-ruptured BTAI might be delayed and allow stabilization, heparinization, and involvement of a higher TEVAR volume surgeon.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mandigers TJ, Yadavalli SD, Rastogi V, et al. Surgeon volume and outcomes following thoracic endovascular aortic repair for blunt thoracic aortic injury. J Vasc Surg. 2024. PMID: 38431064. doi:10.1016/j.jvs.2024.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。